NCT03968055
Enrolling by Invitation
N/A
The Use of Continuous Glucose Monitor Technology and Remote Monitoring to Change Clinical Outcomes Following New Diagnosis of Type 1 Diabetes in the Pediatric Population
ConditionsType 1 Diabetes
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Type 1 Diabetes
- Sponsor
- Stanford University
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Contacts with the care provider
- Status
- Enrolling by Invitation
- Last Updated
- 10 months ago
Overview
Brief Summary
To determine if increased targeted contact between patients and the care team can improve diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to remotely view continuous glucose monitor (CGM) data.
Detailed Description
Based on alerts from GluVue, care team members will proactively reach out to patients and their families for more frequent dose adjustments. We will assess if remote monitoring facilitates contact between the care team and patients and improves glycemic control.
Investigators
Priya Prahalad
Clinical Assistant Professor
Stanford University
Eligibility Criteria
Inclusion Criteria
- •All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic
- •Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic
- •Individuals who agree to CGM data integration into the electronic medical record (EMR) for remote monitoring
- •Age: birth to \< 21 years of age
Exclusion Criteria
- •Diabetes diagnosis other than T1D
- •Diagnosis of diabetes \> 1 month prior to initial visit
- •Individuals with the intention of obtaining diabetes care at another clinic
- •Individuals who do not consent to CGM use, CGM data integration, or remote monitoring
- •Individuals \> 21 years of age
Outcomes
Primary Outcomes
Contacts with the care provider
Time Frame: 1 year
Prospective chart review to determine the number of contacts between the participant and care team due to remote monitoring
Secondary Outcomes
- Hemoglobin A1c(1 year)
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Examining The Role of CGM in T2DMDIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)NCT01614262University of North Carolina, Chapel Hill35
Active, Not Recruiting
N/A
Research on Optimizing the Use of Technology With EducationType 1 DiabetesContinuous Glucose MonitoringBehavioral InterventionParent-Child RelationsNCT05564481Children's National Research Institute60
Completed
N/A
Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active CancerHematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmType 2 Diabetes MellitusNCT04938869Ohio State University Comprehensive Cancer Center3
Terminated
N/A
Continuous Glucose Monitoring to Aid Weight Loss in PrediabetesWeight LossPreDiabetesNCT03844646Stanford University12
Not Yet Recruiting
N/A
Diabetes Self-management With Continuous Glucose MonitoringType 1 DiabetesNCT06453434Nordsjaellands Hospital500